Epigenetics is the study of how external factors, such as diet, environment and lifestyle, can alter gene expression without changing the underlying genetic code. Epigenetic pathways refer to the range of mechanisms that underlie these modifications and control the expression of genes. Epigenetic pathways are regulated by small chemical tags called epigenetic marks that are added to the DNA. These cues tell the cell which genes should be expressed and which should remain inactive. Epigenetic marks can be added or removed to control gene expression and to influence the developmental processes of the cell. Epigenetic marks can either silence genes or activate them. The best studied form of epigenetic silencing is DNA methylation, in which molecules called methyl groups are attached to DNA. These methyl groups block gene activity, by interfering with the proteins that bind to the gene and control its expression. On the other hand, acetylation of histones – proteins that package and organize DNA – can promote gene expression. When acetyl groups are added to histones, they can interact with the DNA and help activate the gene. Complex interactions between epigenetic marks, proteins, and other molecules in the cell create a unique set of configurations that determine how genes are expressed. Researchers are using cutting-edge technologies to understand how these pathways interact and how they can influence gene expression and development. Ultimately, epigenetic pathways play a critical role in many biological processes, such as ageing, cell differentiation, and disease. By understanding how epigenetic pathways work, scientists are unlocking vital information that can be used to develop treatments for diseases and improve human health.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States